Park Ha Biological Technology, which sells skincare and cosmetic products in China, raised $4.8 million by offering 1.2 million shares at $4, the low end of the range of $4 to $6.
Because Park Ha Biological Technology raised less than $5 million, it will be excluded from Renaissance Capital's 2024 IPO stats.
Park Ha Biological Technology plans to list on the Nasdaq under the symbol PHH. Dawson James and D. Boral Capital acted as joint bookrunners on the deal.
